Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Decitabine

EU orphan designation number: EU/3/03/135   
Active ingredient: Decitabine
Indication: Treatment of myelodysplastic syndromes
Sponsor: Janssen-Cilag International NV
Turnhoutseweg 30, B-2340 Beerse, BelgiŽ

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/02/2003 Centralised Orphan - Designation EMEA/OD/059/02 (2003)592 of 14/02/2003
28/03/2006 Centralised Orphan - Transfer of orphan designation EMEA/OD/059/02/T/01 (2006)1044 of 22/03/2006
01/09/2006 Other procedure
27/03/2007 Centralised Orphan - Transfer of orphan designation EMEA/OD/059/02/T/02 (2007)1447 of 23/03/2007